首页> 外文期刊>Annals of surgical oncology >Intraperitoneal Chemotherapy at the Time of Surgery is Not Associated with Increased 30-Day Morbidity and Mortality Following Colorectal Resection
【24h】

Intraperitoneal Chemotherapy at the Time of Surgery is Not Associated with Increased 30-Day Morbidity and Mortality Following Colorectal Resection

机译:手术时的腹膜内化学疗法与大肠切除术后30天发病率和死亡率增加无关。

获取原文
获取原文并翻译 | 示例

摘要

In the absence of large randomized trials, the independent contribution of intraperitoneal chemotherapy (IPC) to morbidity and mortality (M+M) from cytoreductive surgery remains uncertain. In a multi-institutional cohort of colorectal surgery patients, we examined the association between M+M and the use of IPC.
机译:在缺乏大型随机试验的情况下,腹腔内化疗(IPC)对细胞减少手术的发病率和死亡率(M + M)的独立贡献仍然不确定。在多机构大肠外科手术患者队列中,我们检查了M + M与IPC使用之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号